| Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer K Mittal, S Donthamsetty, R Kaur, C Yang, MV Gupta, MD Reid, DH Choi, ... British journal of cancer 116 (9), 1186-1194, 2017 | 113 | 2017 |
| Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers V Pannu, K Mittal, G Cantuaria, MD Reid, X Li, S Donthamsetty, ... Oncotarget 6 (12), 10487, 2015 | 72 | 2015 |
| Prognostic role of androgen receptor in triple negative breast cancer: a multi-institutional study S Bhattarai, S Klimov, K Mittal, U Krishnamurti, X Li, G Oprea-Ilies, ... Cancers 11 (7), 995, 2019 | 68 | 2019 |
| A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas K Mittal, DH Choi, S Klimov, S Pawar, R Kaur, AK Mitra, MV Gupta, ... Journal of ovarian research 9, 1-11, 2016 | 56 | 2016 |
| Acute effect of formalin on pulmonary function tests in medical students BK Binawara, CS Rajnee, KC Mathur, H Sharma, K Goyal Pak J Physiol 6 (2), 8-10, 2010 | 41 | 2010 |
| Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer A Ogden, C Garlapati, X Li, RC Turaga, G Oprea-Ilies, N Wright, ... Scientific reports 7 (1), 42289, 2017 | 36 | 2017 |
| Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ M Toss, I Miligy, K Gorringe, K Mittal, R Aneja, I Ellis, A Green, E Rakha Journal of Clinical Pathology 73 (2), 76-82, 2020 | 33 | 2020 |
| Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells AR Mittal K, Choi DH, Ogden A, Donthamsetty, Melton BD, Gupta MV, Pannu V ... Scientific Reports 7 (43984), 2017 | 30 | 2017 |
| Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies RA Karuna Mittal 1, Jaspreet Kaur 1, Meghan Jaczko 1, Guanhao Wei 1, Michael ... Cancer Metastasis Rev ., 2020 | 29* | 2020 |
| Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma K Mittal, A Ogden, MD Reid, PCG Rida, S Varambally, R Aneja Cell Cycle 14 (17), 2798-2809, 2015 | 28 | 2015 |
| Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ MS Toss, IM Miligy, KL Gorringe, MA Aleskandarany, A Alkawaz, K Mittal, ... Modern Pathology 32 (10), 1460-1472, 2019 | 25 | 2019 |
| The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ MS Toss, IM Miligy, R Haj‐Ahmad, KL Gorringe, A AlKawaz, K Mittal, ... Histopathology 74 (7), 1025-1035, 2019 | 21 | 2019 |
| Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study MS Toss, IM Miligy, KL Gorringe, A AlKawaz, K Mittal, R Aneja, IO Ellis, ... Modern Pathology 32 (10), 1473-1485, 2019 | 13 | 2019 |
| Hypoxia drives centrosome amplification in cancer cells via HIF1α-dependent induction of polo-like kinase 4 K Mittal, J Kaur, S Sharma, N Sharma, G Wei, I Choudhary, ... Molecular Cancer Research 20 (4), 596-606, 2022 | 12 | 2022 |
| A novel biosignature identifies patients with DCIS with high risk of local recurrence after breast conserving surgery and radiation therapy FA Vicini, GB Mann, C Shah, S Weinmann, MC Leo, P Whitworth, ... International Journal of Radiation Oncology* Biology* Physics 115 (1), 93-102, 2023 | 10 | 2023 |
| Hypoxia-induced centrosome amplification underlies aggressive disease course in HPV-negative oropharyngeal squamous cell carcinomas K Mittal, DH Choi, G Wei, J Kaur, S Klimov, K Arora, CC Griffith, M Kumar, ... Cancers 12 (2), 517, 2020 | 9 | 2020 |
| Panoptic view of prognostic models for personalized breast cancer management G Saini, K Mittal, P Rida, EAM Janssen, K Gogineni, R Aneja Cancers 11 (9), 1325, 2019 | 8 | 2019 |
| A quantitative centrosomal amplification score predicts local recurrence of ductal carcinoma in situ K Mittal, MS Toss, G Wei, J Kaur, DH Choi, BD Melton, RM Osan, IM Miligy, ... Clinical Cancer Research 26 (12), 2898-2907, 2020 | 6* | 2020 |
| Spotlighting the hypoxia-centrosome amplification axis. KM Ritu Aneja Med Res Rev., 2020 | 5 | 2020 |
| Evaluation of centrosome clustering protein KIFC1 as a potential prognostic biomarker in serous ovarian adenocarcinomas. K Mittal, DH Choi, S Klimov, S Pawar, R Kaur, A Mitra, MV Gupta, R Sams, ... Journal of Clinical Oncology 34 (15_suppl), e17083-e17083, 2016 | 5 | 2016 |
